AOS vs DAWN · P/E 19, rev $1.00B vs rev $131.2M
Smith AO Corporation (AOS) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the AOS and DAWN stock pages for the full models.
Not investment advice.